Oxford Heart Centre, Oxford University Hospitals, Oxford, UK.
Imperial College Healthcare NHS Trust, London, UK.
Am Heart J. 2019 Sep;215:70-77. doi: 10.1016/j.ahj.2019.05.014. Epub 2019 Jun 14.
Infective endocarditis is a life-threatening complication of congenital heart disease (CHD), but there are few studies concerning the contemporary risk profile, preceding invasive procedures and outcomes in this patient population. The aim of this study was to investigate the epidemiology of infective endocarditis (IE) in patients with CHD.
Cases of IE in children and adults with CHD were prospectively recorded as part of the UK National Institute for Cardiovascular Outcomes Research (NICOR) National Congenital Heart Disease Audit. Patients were entered into the database between April 2008 and March 2016.
Eight hundred episodes of IE were recorded in 736 patients with CHD. Sixty-five patients (9%) were infants (aged <1 year), 235 (32%) were children (aged 1-15 years), and 436 (59%) were adults (aged >15 years). The most common diagnoses were Tetralogy of Fallot (n = 150, 22.8%), ventricular septal defect (n = 129, 19.6%) and bicuspid aortic valve (n = 70, 10.7%). Dental procedures preceded 67 of 635 episodes (11%) of IE, and non-dental invasive procedures preceded 177 of 644 episodes (27.4%). The most common causative organisms were streptococci, accounting for 40% of cases. Overall in-hospital mortality was 6.7%. On multivariable analysis, adverse factors associated with in-hospital mortality were staphylococcal infection and presence of an underlying atrioventricular septal defect.
Infective endocarditis in patients with CHD is an ongoing clinical challenge. In contemporary practice in tertiary congenital centers, 1 of 15 patients do not survive to hospital discharge. Streptococci remain the most common causative organism, and antecedent dental or medical procedures were undertaken in a significant minority in the 3 months before diagnosis. The presence of an atrioventricular septal defect or staphylococcal infection is associated with significantly increased risk of early mortality.
感染性心内膜炎是先天性心脏病(CHD)的一种危及生命的并发症,但关于该患者人群的当代风险状况、侵入性操作前的情况和结局,研究甚少。本研究旨在调查 CHD 患者感染性心内膜炎(IE)的流行病学。
IE 病例作为英国国家心血管结局研究(NICOR)国家先天性心脏病监测的一部分,前瞻性地记录在患有 CHD 的儿童和成人患者中。患者于 2008 年 4 月至 2016 年 3 月期间被纳入数据库。
在 736 例 CHD 患者中记录了 800 例 IE 发作。65 例(9%)为婴儿(<1 岁),235 例(32%)为儿童(1-15 岁),436 例(59%)为成人(>15 岁)。最常见的诊断是法洛四联症(n=150,22.8%)、室间隔缺损(n=129,19.6%)和二叶式主动脉瓣(n=70,10.7%)。635 例 IE 发作中有 67 例(11%)与牙科操作有关,644 例 IE 发作中有 177 例(27.4%)与非牙科侵入性操作有关。最常见的病原体为链球菌,占 40%。总体住院死亡率为 6.7%。多变量分析显示,与住院期间死亡相关的不良因素是葡萄球菌感染和存在房室间隔缺损。
CHD 患者的感染性心内膜炎仍然是一个持续存在的临床挑战。在三级先天性中心的当代实践中,每 15 例患者中就有 1 例在出院前死亡。链球菌仍然是最常见的病原体,在诊断前 3 个月内,有相当一部分患者进行了牙科或医疗操作。存在房室间隔缺损或葡萄球菌感染与早期死亡率显著增加相关。